My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Johnson & Johnson (NY:JNJ)

201.93 -0.55 (-0.27%)

Official Closing Price Updated: 7:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Consumer Brands Shake Things Up...With Mergers ↗

November 17, 2025

2025 has been quite the year for consumer brands, but not in a good way. The industry has underperformed for the past three years and many of the world's largest consumer brand companies are resorting...

Via The Motley Fool

Topics Artificial Intelligence Economy

Johnson & Johnson Adds Prostate Cancer Candidate In Around $3 Billion Halda Deal ↗

November 17, 2025

Johnson & Johnson buys Halda for $3.05 billion, adding a prostate cancer candidate as new Tremfya Phase 3b data show sustained benefits through 48 weeks.

Via Benzinga

Valuation Fears Ignite "Great Rotation" in Global Markets as Investors Seek Shelter from Elevated Prices

November 17, 2025

Global financial markets are currently gripped by a palpable sense of unease, as elevated valuations, particularly within the high-flying technology and Artificial Intelligence (AI) sectors, spark...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Court Rejects Bid To Block Kenvue's $398 Million Shareholder Payout In Tylenol Safety Dispute ↗

November 17, 2025

Texas judge rejects bid to block Kenvue's $398 million dividend and declines to restrict Tylenol marketing as the company faces a lawsuit over pregnancy safety claims.

Via Benzinga

Topics Lawsuit

Navigating the Tides: Long-Term Investment Strategies for a Fluctuating Stock Market

November 17, 2025

In a financial landscape perpetually shaped by unpredictability, long-term investment strategies emerge as the crucial anchor for investors navigating the volatile stock market. As of November 17,...

Via MarketMinute

Topics Artificial Intelligence Bonds ETFs

Navigating the Tempest: Market Volatility Surges Amidst Investor Caution and Economic Uncertainty

November 17, 2025

As November 2025 unfolds, global financial markets find themselves in a turbulent sea of heightened volatility, prompting a pervasive sense of caution among investors. A complex interplay of economic...

Via MarketMinute

Topics Artificial Intelligence Bonds Credit Cards

Labor Market Jitters Send Shockwaves Through Wall Street: Investors Brace for Economic Slowdown Amidst Delayed Data

November 17, 2025

The financial markets are grappling with a turbulent period as recent labor market reports, particularly those reflecting October 2025 data, paint a picture of a weakening economy. With official...

Via MarketMinute

Topics Bonds Economy Stocks

Johnson & Johnson Inks A $3.05 Billion Deal In Cancer Treatment ↗

November 17, 2025

Johnson & Johnson said Monday it's putting up $3.05 billion to buy privately held cancer player Halda Therapeutics.

Via Investor's Business Daily

Johnson & Johnson Set to Revolutionize the Treatment of Cancer With the Acquisition of Halda Therapeutics

November 17, 2025

From Johnson & Johnson

Via Business Wire

Healthcare Sector Navigates Mixed Market Close: A Beacon of Stability Amidst Uncertainty

November 14, 2025

As the broader market concluded with a mixed performance on November 14, 2025, the S&P 500 Healthcare sector once again underscored its often-defensive nature, demonstrating resilience amidst an...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Federal Reserve's Hawkish Stance Crushes Gold and Silver, Dashing December Rate Cut Hopes

November 14, 2025

Washington D.C. – November 14, 2025 – Recent hawkish pronouncements from Federal Reserve officials have sent shockwaves through the financial markets, particularly impacting precious metals. Gold and...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

AI and Digital Twins Ignite a New Era of Accelerated Drug Discovery and Development

November 14, 2025

The pharmaceutical industry is on the cusp of a profound transformation, driven by the synergistic power of artificial intelligence (AI) and digital twins. These cutting-edge technologies are rapidly...

Via TokenRing AI

Topics Artificial Intelligence

Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025

November 14, 2025

The pharmaceutical and biotechnology sectors are experiencing a period of significant dynamism and robust growth as of November 2025, fueled by a confluence of scientific advancements, a resurgence in...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Global Markets Shaken by AI Concerns and Rate Cut Doubts, Wall Street Stages Volatile Recovery

November 14, 2025

New York, NY – November 14, 2025 – Global financial markets have recently experienced a significant upheaval, marked by a sharp stock selloff driven primarily by escalating concerns over the lofty...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Bristol Myers Faces Another Trial Disappointment As Heart Drug Milvexian Fails To Show Efficacy ↗

November 14, 2025

Bristol Myers and Johnson & Johnson ended the Librexia ACS trial after an interim review showed low efficacy, while AF and stroke studies continue with data expected in 2026.

Via Benzinga

Market Rally Stumbles: Investors Grapple with Shifting Sentiments Amidst Economic Headwinds

November 14, 2025

November 14, 2025 – The once-exuberant stock market rally has unequivocally hit a snag, with palpable signs of anxiety now rippling through global financial markets. What was a period of sustained...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Stock Market Plunges: Dow Drops 500 Points Amid Broad Sell-Off and Escalating Investor Fear

November 14, 2025

The U.S. stock market is currently in the throes of a significant downturn, with the Dow Jones Industrial Average (DJIA) plummeting 500 points on November 14, 2025, extending a week of losses that has...

Via MarketMinute

Topics Artificial Intelligence ETFs Economy

Bristol Myers Slumps After Its Heart Condition Study Gets The Boot ↗

November 14, 2025

An independent data monitoring committee said the company's treatment for acute coronary syndrome was likely to fail in testing.

Via Investor's Business Daily

BMY Stock Slumps 5% After It Scraps Heart Drug Study ↗

November 14, 2025

The decision follows an analysis by an independent data monitoring committee that the trial is unlikely to meet its key goal.

Via Stocktwits

AI Revolutionizes Cardiovascular Clinical Trials: A Leap Towards Cheaper, Faster Drug Development

November 13, 2025

San Francisco, CA – November 13, 2025 – Artificial Intelligence (AI) has achieved a pivotal breakthrough in the medical field, successfully adjudicating clinical events in cardiovascular trials. This...

Via TokenRing AI

Topics Artificial Intelligence

Post-Shutdown Jitters: Markets Reel as Government Reopens

November 13, 2025

The United States government, after an unprecedented 43-day shutdown, officially reopened on Thursday, November 13, 2025, as President Donald Trump signed a funding bill into law. While the resolution...

Via MarketMinute

Topics Bonds Economy Government

A Look Into Johnson & Johnson Inc's Price Over Earnings ↗

November 13, 2025

Via Benzinga

Decoding Johnson & Johnson's Options Activity: What's the Big Picture? ↗

November 13, 2025

Via Benzinga

Market Jitters Persist as Wall Street Opens Lower Amidst Economic Headwinds and Geopolitical Tensions

November 13, 2025

Wall Street experienced a turbulent start to the trading day, opening lower as a complex web of market uncertainties continued to weigh heavily on investor sentiment. A confluence of factors, including...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Market Sentiment Pivots: From Momentum to Caution in Late 2025

November 13, 2025

As November 2025 unfolds, the financial markets are witnessing a palpable shift in sentiment, moving away from a period of sustained, growth-driven momentum towards a more circumspect and cautious...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Post-Shutdown Data Deluge: Markets Brace for Economic Reckoning as US Government Reopens

November 13, 2025

The United States government has recently emerged from its longest shutdown in history, a 43-day impasse that concluded on November 12, 2025. This protracted closure plunged the nation into an...

Via MarketMinute

Topics Credit Cards Economy World Trade

Dow's Resilient Dance: Navigating Pullback Worries Amidst Tech Valuation Scrutiny

November 13, 2025

The venerable Dow Jones Industrial Average (DJIA) has recently demonstrated a remarkable display of resilience, quickly shrugging off "pullback worries" in early November 2025 to achieve fresh record...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

2 Healthcare Stocks for Beginner Investors With a 40-Year Time Horizon ↗

November 13, 2025

If you're a new investor looking for some long-term opportunities, don't overlook these top healthcare buys.

Via The Motley Fool

2 Strong Healthcare Stock Picks for Dividend Investors ↗

November 13, 2025

These top dividend payers could enrich a long-term investor's portfolio.

Via The Motley Fool

Topics Economy

Economic Blind Spot: White House Announces October CPI Data May Never See Light Amidst Shutdown

November 12, 2025

Washington D.C. – November 12, 2025 – In an unprecedented move that has sent ripples of concern through financial markets and economic policy circles, the White House announced that the crucial October...

Via MarketMinute

Topics Bonds Economy

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.